BLFS insider trading
NasdaqCM HealthcareBIOLIFE SOLUTIONS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About BIOLIFE SOLUTIONS INC
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Company website: www.biolifesolutions.com
BLFS insider activity at a glance
FilingIQ has scored 1,588 insider transactions for BLFS since Mar 24, 2015. The most recent filing in our index is dated Apr 8, 2026.
Across the full history, 14 open-market purchases
and 928 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BLFS insider trades is 57.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest BLFS Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading BLFS
13F funds holding BLFS
Frequently asked
- How many insider trades does FilingIQ track for BLFS?
- FilingIQ tracks 1,588 Form 4 insider transactions for BLFS (BIOLIFE SOLUTIONS INC), covering filings from Mar 24, 2015 onwards. 44 of those were filed in the last 90 days.
- Are BLFS insiders net buyers or net sellers?
- Across the full Form 4 history for BLFS, 14 transactions (1%) were open-market purchases and 928 (58%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BLFS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is BLFS in?
- BIOLIFE SOLUTIONS INC (BLFS) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $1.10B.
Methodology & sources
Every BLFS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.